Literature DB >> 19928060

[Synthesis and biological activity of new glycyrrhizic acid conjugates with amino acids and dipeptides].

L A Baltina, R M Kondratenko, L A Baltina, N Zh Baschenko, O A Pliasunova.   

Abstract

New glycyrrhizic acid (GA) conjugates were synthesized with the use of tert-butyl esters of amino acids or benzyl esters of dipeptides; they contained two residues of L-amino acids (Met, Phe, Pro, and Ile or dipeptides Gly-Leu and Gly-Phe). Activation of GA carboxy groups was carried out with the help of N-hydroxysuccinimide, N,N'-dicyclohexylcarbodiimide, or N-hydroxybenzotriazole with dicyclohexylcarbodiimide. A proline-containing GA derivative is a low-toxic substance; it raises the level of agglutinins by 3.7 times in the blood of mice and 3 times that of hemolysins compared with the control. Dipeptide GA derivatives possess an expressed anti-HIV-1 activity in cultures of MT-4 cells and are 90-70 times less cytotoxic than azidothymidine. The selectivity index of the compounds exceeds those of GA by 110 and 34 times, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19928060      PMCID: PMC7088709          DOI: 10.1134/s1068162009040141

Source DB:  PubMed          Journal:  Bioorg Khim        ISSN: 0132-3423


  5 in total

Review 1.  Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection.

Authors:  E De Clercq
Journal:  Med Res Rev       Date:  2000-09       Impact factor: 12.944

2.  [Synthesis and immunomodulating activity of new glycopeptides of glycyrrhizic acid containing residues of L-glutamic acid].

Authors:  R M Kondratenko; L A Baltina; L A Baltina; N Zh Baschenko; G A Tolstikov
Journal:  Bioorg Khim       Date:  2006 Nov-Dec

3.  Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis.

Authors: 
Journal:  Hepatol Res       Date:  2001-01-01       Impact factor: 4.288

4.  [Transformations of glycyrrhizic acid. VIII. Synthesis of immunomodulating glycopeptides using tert-butyl amino acid esters].

Authors:  L A Baltina; S A Ryzhova; E V Vasil'eva; G A Tolstikov; G M Sakhautdinova; F S Zarudiĭ
Journal:  Bioorg Khim       Date:  1994-12

5.  Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].

Authors:  M Ito; H Nakashima; M Baba; R Pauwels; E De Clercq; S Shigeta; N Yamamoto
Journal:  Antiviral Res       Date:  1987-03       Impact factor: 5.970

  5 in total
  6 in total

Review 1.  Recent advances in natural anti-HIV triterpenoids and analogs.

Authors:  Hai-Feng Wu; Susan L Morris-Natschke; Xu-Dong Xu; Mei-Hua Yang; Yung-Yi Cheng; Shi-Shan Yu; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2020-07-14       Impact factor: 12.944

2.  1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide in the Synthesis of Glycyrrhizic Acid Amino-Acid Conjugates.

Authors:  L A Baltina; L A Baltina; R M Kondratenko; S F Petrova
Journal:  Chem Nat Compd       Date:  2020-06-05       Impact factor: 0.809

3.  Glycyrrhizic acid derivatives as influenza A/H1N1 virus inhibitors.

Authors:  Lidia A Baltina; Vladimir V Zarubaev; Lia A Baltina; Iana A Orshanskaya; Alina I Fairushina; Oleg I Kiselev; Marat S Yunusov
Journal:  Bioorg Med Chem Lett       Date:  2015-03-07       Impact factor: 2.823

4.  New method of preparation of carboxy-protected amino acid conjugates of glycyrrhizinic acid.

Authors:  L A Baltina; A I Fairushina; L A Baltina
Journal:  Russ J Gen Chem       Date:  2016-05-24       Impact factor: 0.868

5.  Synthesis of amino acid conjugates of glycyrrhizic acid using N-hydroxyphthalimide and N,N'-dicyclohexylcarbodiimide.

Authors:  L A Baltina; A I Fairushina; L A Baltina
Journal:  Russ J Gen Chem       Date:  2016-02-06       Impact factor: 0.868

6.  Effect of two glycyrrhizinic acid nanoparticle carriers on MARC-145 cells actin filaments.

Authors:  Samantha Jardon; Carlos G García; David Quintanar; José L Nieto; María de Lourdes Juárez; Susana E Mendoza
Journal:  Appl Nanosci       Date:  2018-04-13       Impact factor: 3.674

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.